Shandong Kexing Bioproducts Co,.Ltd (688136.SS)
CNY 35.17
(17.23%)
CNY 35.17
(17.23%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -254.2 Million CNY | -112.18% |
| 2022 | -119.8 Million CNY | -315.6% |
| 2021 | 55.56 Million CNY | -65.24% |
| 2020 | 159.84 Million CNY | -15.42% |
| 2019 | 188.98 Million CNY | 55.84% |
| 2018 | 121.27 Million CNY | 35.78% |
| 2017 | 89.31 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 7.96 Million CNY | -84.17% |
| 2024 Q1 | 15.84 Million CNY | 108.72% |
| 2024 Q2 | 50.3 Million CNY | 217.54% |
| 2023 Q2 | -55.87 Million CNY | -226.18% |
| 2023 FY | -254.2 Million CNY | -112.18% |
| 2023 Q3 | 495 Thousand CNY | 100.89% |
| 2023 Q1 | -17.13 Million CNY | 67.48% |
| 2023 Q4 | -181.68 Million CNY | -36803.75% |
| 2022 Q3 | -79.37 Million CNY | -99.47% |
| 2022 Q2 | -39.79 Million CNY | -230.74% |
| 2022 Q1 | 30.43 Million CNY | 70.93% |
| 2022 FY | -119.8 Million CNY | -315.6% |
| 2022 Q4 | -52.67 Million CNY | 33.64% |
| 2021 FY | 55.56 Million CNY | -65.24% |
| 2021 Q3 | 14.37 Million CNY | 8.93% |
| 2021 Q4 | 17.8 Million CNY | 23.9% |
| 2021 Q1 | 52.63 Million CNY | 129.39% |
| 2021 Q2 | 13.19 Million CNY | -74.93% |
| 2020 Q3 | 23.75 Million CNY | 266.94% |
| 2020 FY | 159.84 Million CNY | -15.42% |
| 2020 Q4 | 22.94 Million CNY | -3.43% |
| 2020 Q2 | 6.47 Million CNY | -93.93% |
| 2020 Q1 | 106.67 Million CNY | 108.9% |
| 2019 Q3 | 35.06 Million CNY | 0.0% |
| 2019 FY | 188.98 Million CNY | 55.84% |
| 2019 Q4 | 51.06 Million CNY | 45.62% |
| 2018 FY | 121.27 Million CNY | 35.78% |
| 2017 FY | 89.31 Million CNY | 0.0% |